1st Quarter - Report

HARMONY BIOSCIENCES for HARMONY BIOSCIENCES

Firm
Client
Income
—
Expenses
$250,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Issues related to the development of therapies for rare diseases and sleep disorders; drug pricing; and access to non-controlled medications. H.R.1350, Camerons Law. FY24 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations. H.R. 1805, The Rare Disease Clinical Trials Pandemic Disruption Act. Reauthorization of the Pandemic and All-Hazards Preparedness Act.

LobbyistCovered position, as disclosed
CATE MCCANLESS —
GEOFFREY WERTH —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 1350 (118th), H.R. 1805 (118th)

Medicare/Medicaid MMM

Issues related to Medicare Part D redesign. H.R. 2673, The American Innovation and R&D Competitiveness Act.

LobbyistCovered position, as disclosed
CATE MCCANLESS —
GEOFFREY WERTH —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 2673 (118th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.